C.H. Boehringer Sohn / Boehringer Ingelheim
- Pharmaceutical Sales 2011
-
worldwide: 13.171 billion EUR
in Germany: 0.95 billion EUR
- Product Range
- Pharmaceuticals for treating respiratory diseases, cardio-metabolic diseases, neurological diseases and infectious diseases, for immunology and oncology as well as several indications in the field of self-medication
- Key Research Areas
- Respiratory diseases, Cardio-metabolic diseases, oncology, neurological diseases, immunology, infectious diseases
- R&D Expenditure 2011
-
worldwide: 2.615 billion EUR
- Employees in the Pharmaceuticals Division 2011
-
worlwide: 44,094
in Germany: 10,357
(All data based on corporate information, as of: 05/2012)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page